The company is currently advancing a strong pipeline of new chemistry leads as demonstrated below:
|
P-216 - The Company’s lead antibiotic product is a new class of narrow spectrum peptide antibiotic that exhibits potent and broad antimicrobial activity across a wide range of MRSA, VRSA, VISA and VREs. The compound was discovered from an extract of a new species of marine fungus. |
P-1639 is currently being assessed in personal / consumer healthcare applications. |